Compare WRBY & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRBY | VCYT |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2021 | 2013 |
| Metric | WRBY | VCYT |
|---|---|---|
| Price | $23.71 | $33.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $26.67 | ★ $45.13 |
| AVG Volume (30 Days) | ★ 3.1M | 803.7K |
| Earning Date | 06-01-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 105.88 | ★ 164.52 |
| EPS | 0.01 | ★ 0.82 |
| Revenue | ★ $871,905,000.00 | N/A |
| Revenue This Year | $14.81 | $13.33 |
| Revenue Next Year | $15.98 | $12.53 |
| P/E Ratio | $2,363.00 | ★ $40.78 |
| Revenue Growth | ★ 13.04 | N/A |
| 52 Week Low | $13.63 | $22.61 |
| 52 Week High | $31.00 | $50.71 |
| Indicator | WRBY | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 42.44 |
| Support Level | $21.47 | $32.51 |
| Resistance Level | $28.86 | $34.89 |
| Average True Range (ATR) | 1.55 | 1.27 |
| MACD | -0.19 | 0.03 |
| Stochastic Oscillator | 15.14 | 34.34 |
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).